咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Etanercept in axial spondyloar... 收藏

Etanercept in axial spondyloarthritis

Etanercept in axial spondyloarthritis

作     者:Gui Luo Jian Zhu Gui Luo;Jian Zhu

作者机构:Department of Rheumatology and ImmunologyThe First Medical CenterChinese PLA General HospitalBeijing 100853China 

出 版 物:《Chinese Medical Journal》 (中华医学杂志(英文版))

年 卷 期:2022年第135卷第21期

页      面:2628-2630页

核心收录:

学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

主  题:axial patients pain 

摘      要:To the Editor:Axial spondyloarthritis(axSpA)is a chronic and progressive disease affecting the spine and sacroiliac(SI)joints,causing inflammatory back pain,stiffness,and inducing new bone formation(syndesmophytes and ultimately ankylosis in the severe forms).AxSpA consists of two subsets of patients:those with non-radiographic axSpA(nr-axSpA)and those with ankylosing spondylitis(AS),also known as radiographic axSpA.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分